Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Showing posts with label Hepatitis C in Egypt. Show all posts
Showing posts with label Hepatitis C in Egypt. Show all posts

Wednesday, July 8, 2015

2 new hepatitis C drugs to be available in November in Egypt

CAIRO: Minister of Health Adel al-Adawy announced that two new hepatitis C drugs, Harvoni and Viekira, are to be available at the hepatitis treatment centers by next November, youm7 reported Wednesday.

There are 2.3 million hepatitis C patients in Egypt, while 996,642 patients applied on the website of the National Committee for the Control of Viral Hepatitis to be treated by Sovaldi until last June, according to Adawy.

He added that 85,536 patients were provided with the treatment until the end of June.

Read more...

Monday, March 9, 2015

U.S. Congress to give Egypt $35M to fight hep C

CAIRO: Health minister Adel Adwy announced that the U.S. Congress decided to give the ministry $35 million to help eliminate hepatitis C from Egypt, Youm7 reported Saturday night.

Adwy said that Egypt can completely eliminate HCV within 10 years,  adding that the real partnership with international bodies doesn’t aim only for treatment, but prevention.

Egypt has the highest hepatitis C infection rate in the world, according to the WHO. Last year the government began a program to distribute the American-made treatment Sovaldi at an extreme discount offered by the manufacturer, Gilead.

Read more...